Eyelid surgery for upper visual field improvement: ASPS clinical practice guideline
USA: A recent article reports the American Society of Plastic Surgeons' evidence-based clinical practice guidelines for the management of upper visual field impairments related to eyelid ptosis and dermatochalasis. The goal of the guideline, published in Plastic and Reconstructive Surgery, was to provide evidence-based recommendations to improve patient care.
For developing the guideline, a multidisciplinary group of experts representing their specialty organizations was selected. A systematic literature review was performed and the Grading of Recommendations, Assessment, Development, and Evaluation methodology process was used to evaluate the relevant studies.
The workgroup recommends that for patients presenting with low upper eyelid position obstructing the superior visual field, clinicians obtain the following: A clinical history, which should include an objective assessment of the impact on visual field or activities of daily living; http://webservices.ovid.com/mrws/1.0">and perform a physical examination to assess upper eyelid position relative to the pupil. The examination should differentiate whether the cause of the visual field obstruction is because of excess skin (dermatochalasis) or the low position of the eyelid margin (blepharoptosis). The margin reflex distance 1 and the levator function should be assessed. Photographs of the eyelids should be taken.
Recommendation 2A: The workgroup suggests that surgeons not perform blepharoplasty alone (i.e., without ptosis correction) for patients presenting with diagnosed blepharoptosis.
Recommendation 2B: The workgroup suggests that surgeons perform concurrent upper eyelid blepharoplasty and ptosis correction in patients presenting with dermatochalasis and blepharoptosis.
Recommendation 2C: The workgroup suggests that surgeons perform upper eyelid blepharoplasty in patients presenting with dermatochalasis without underlying ptosis.
Recommendation 3A: The workgroup recommends that surgeons should perform anterior ptosis correction for patients diagnosed with severe upper eyelid ptosis.
Recommendations 3B: It is an option for surgeons to perform either anterior or posterior ptosis correction for patients diagnosed with mild or moderate upper eyelid ptosis.
There is insufficient evidence to support a recommendation.
The workgroup suggests that surgeons may use local anesthesia for patients presenting for upper eyelid ptosis correction and/or blepharoplasty.
It is an option for surgeons to perform adjunctive brow surgery in patients presenting with dermatochalasis and coexisting brow and upper eyelid ptosis.
It is an option for surgeons to perform levator plication http://webservices.ovid.com/mrws/1.0">or levator advancement for patients presenting with upper eyelid ptosis.
The workgroup recommends that patients should have a postoperative follow-up assessment for complications, such as lagophthalmos and eyelid asymmetry. This should occur within 1 to 3 months following upper eyelid blepharoplasty and/or ptosis correction and again at 9 months to 1 year to evaluate cosmetic symmetry and functional outcomes.
"The review of the literature revealed varied complication rates and diverse treatment modalities for the correction of upper visual field deficit. Strong recommendations could not be made in most topic areas because of a paucity of methodologically sound studies in the literature," the researchers wrote. "More rigorously designed studies are needed to measure outcomes of interest, with fewer sources of potential error or bias."
Kim, Kenneth K. M.D.; Granick, Mark S. M.D.; Baum, Gregory A. M.D.; Beninger, Francis M.D.; Cahill, Kenneth V. M.D.; Donnelly, Katelyn C. M.P.H.; Kaidi, Ashton A. M.D.; Kang, Ajaipal S. M.D.; Loeding, Lauren M.P.H.; Loyo, Myriam M.D.; Patel, Parit A. M.D., M.B.A.; Roostaeian, Jason M.D.; Taghva, Goretti Ho M.D.; Varkarakis, George M. M.D.. American Society of Plastic Surgeons Evidence-Based Clinical Practice Guideline: Eyelid Surgery for Upper Visual Field Improvement. Plastic and Reconstructive Surgery: August 2022 - Volume 150 - Issue 2 - p 419e-434e doi: 10.1097/PRS.0000000000009329.
Medha, MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at firstname.lastname@example.org. Contact no. 011-43720751